Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Method To Predict Three-Dimensional Radiotherapy Dose Distribution


Technology Application

This technology opens up a number of new possible applications in treatment planning optimization and plan evaluation.  Some of these include: ·    Immediately after contour approval, radiation oncologists would have an expected treatment plan dose distribution to review, both guiding and accelerating the clinical decision making process for fractionation, target/organ prioritization, etc. ·     Treatment planners would have a powerful new diagnostic  tool  for  understanding exactly where sub-optimal plans are failing, increasing efficiency and further eliminating human failure from the planning process. ·   New voxel-based optimization methods could be  designed  around  these   predictions, eliminating the need to convert DVH  predictions to DVH-based optimization objectives and relative priorities. It is possible that this technology will herald yet another huge leap forward  in  clinical treatment planning, and in time the history of treatmentplanning advances could seen as:  2D àà 3D-conformal àà IMRT/RapidArc àà 1D-KBP àà 3D-KBP.


Detailed Technology Description

At UC San Diego, we have developed a major advance in knowledge-based treatment planning: full 3D dose distribution prediction. Similar to existing art1 our method  relies  on learning  from  a plurality of previously treated plans, but our method moves far beyond current technology to synthesize  past  experience  into  voxel-by-voxel  predictions  for expected  dose  distributions  for  new patients. Our current embodiment already meets or exceeds the accuracy of existing technology in DVH prediction, with the invaluable addition of identifying (a) precisely where the dose is expected to be deposited in the patient and (b) the degree of confidence in that voxel-by-voxel prediction. 1 See in particular US20120310615 (on which Dr. Kevin Moore was the lead inventor) and US20120014507.


Application No.

20170340900


Others

Tech ID/UC Case

24737/2015-046-0


Related Cases

2015-046-0


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View